Skip to main content
APhA DrugInfoLine
Sign in to your APhA membership account
Download a PDF of this month's content | Download a PDF of last month's content |Advanced Search
  • HOME
  • NEURO/PSYCH
    • Neurology
    • Psychiatry
  • HEART/LUNGS
    • Cardiology
    • Focus on Lipids Care
    • Focus on Anticoagulation Care
    • Respiratory
    • Focus on Asthma Care
  • GI/KIDNEYS
    • Gastroenterology
    • Nephrology
  • ENDOCRINE/RHEUM
    • Endocrinology
    • Focus on Diabetes Care
    • Rheumatology
  • ID/CANCERS
    • Infectious Diseases
    • Focus on HIV Care
    • Focus on Immunizations
    • Oncology
  • SELF-CARE
    • Alternative Medicines Corner
    • OTC Medicines Corner
  • PERSONALIZED CARE
    • Drug Interactions Corner
    • Pharmacogenomics Corner
  • Heart/Lungs
    Focus on Lipids Care...
    December 10, 2019

    Study shows statin dose may affect the risk of osteoporosis

    READ
  • Heart/Lungs
    Focus on Asthma Care...
    December 10, 2019

    Response to step-up therapy in asthma may differ in black children compared with black adolescents and adults

    READ
  • Heart/Lungs
    Focus on Asthma Care...
    December 2, 2019

    As-needed corticosteroid–beta-agonist inhalers for adults with...

    READ
  • Heart/Lungs
    Cardiology...
    December 2, 2019

    Survey suggests overuse of aspirin for primary prevention of CVD

    READ
  • Heart/Lungs
    Focus on Asthma Care...
    November 26, 2019

    Triple therapy in a single inhaler improves asthma symptoms and...

    READ
  • Self-care
    OTC Medicines Corner...
    November 26, 2019

    Analysis suggests OTC oral contraceptives may improve access,...

    READ
  • Endocrine/Rheum
    Rheumatology...
    November 18, 2019

    Non-TNFi biologics may be more effective than TNFis for...

    READ
  • ID/Cancers
    Focus on Immunizations...
    November 18, 2019

    CDC publishes updated HPV vaccination recommendations for adults

    READ
  • Heart/Lungs
    Cardiology...
    November 12, 2019

    Recent study finds dapagliflozin improves heart failure outcomes...

    READ
  • Self-care
    OTC Medicines Corner...
    November 12, 2019

    Topical capsaicin may be an option for severe vomiting...

    READ
  • ID/Cancers
    Infectious Diseases...
    November 5, 2019

    Fluoroquinolone use is decreasing, apparently because of safety...

    READ
  • Read more about Aclidinium not shown to increase CV risk in patients with COPD
  • Read more about Newer antiandrogens are effective for metastatic, hormone-sensitive prostate cancer
  • Read more about FDA warns consumers not to use potentially life-threatening 'Miracle Mineral Solution' products
  • Read more about Two lots of 40-mg tablets recalled for microbiological contamination
  • Read more about First-in-class med reduces excessive daytime sleepiness in adult patients with narcolepsy
  • Read more about New oral JAK inhibitor treats moderate to severe rheumatoid arthritis
  • Read more about New antibiotic targets community-acquired bacterial pneumonia in adults
  • Read more about New drug targets myelofibrosis, a rare bone marrow disorder
  • Read more about FDA approves third oncology drug that targets a key genetic driver
  • Read more about FDA approves new drug for treatment-resistant forms of pulmonary TB

Medication Monitor

NEW DRUG APPROVALS

  • December 2, 2019
    Voxelotor
    (Oxbryta):
    FDA approves voxelotor for sickle cell disease
  • November 26, 2019
    Cenobamate
    (Xcopri):
    FDA approves cenobamate tablets for adults with partial-onset seizures
See more New Drug Approvals

SUPPLEMENTAL APPROVALS

  • November 26, 2019
    Riluzole oral film
    (Exservan):
    Riluzole oral film approved for patients with ALS
  • November 26, 2019
    Acalabrutinib
    (Calquence):
    Acalabrutinib now approved for treatment of adults with CLL, SLL
See more Supplemental Approvals

ALERTS AND RECALLS

  • September 26, 2019
    Palbociclib, ribociclib, abemaciclib
    (Ibrance, Kisqali, Verzenio):
    FDA warns of breast cancer drugs that may cause severe lung inflammation
See more Alerts and Recalls

PRODUCT WITHDRAWALS

  • March 26, 2018
    Daclizumab
    (Zinbryta):
    Daclizumab withdrawn after reports of serious inflammatory brain disorders
See more Product withdrawals


                                

Editor's Picks

  • Study shows statin dose may affect the risk of...
  • Response to step-up therapy in asthma may differ...
  • Survey suggests overuse of aspirin for primary...
  • Triple therapy in a single inhaler improves...
  • Analysis suggests OTC oral contraceptives may...

Popular Articles

  • Another negative trial for vitamin D...
  • New data support apixaban over rivaroxaban for...
  • ASH releases new VTE guidelines
  • New analysis highlights the cardiorenal benefits...
  • New guideline on management of diabetes in older...

Popular Sections

  • Alerts and Recalls
  • Supplemental Approvals
  • New Drug Approvals
  • Cardiology
  • Alternative Medicines Corner

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.

  • Contact Us
  • Section Advisors
  • Terms of Use
  • Privacy Policy